Sulzer Shareholders Must Weigh Value Of Non-Medical Businesses
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Ltd. will have to convince its shareholders before the firm's April 19 annual meeting that a share in the non-medical portion of its business has a greater value than the $241-per-share cash component of investor group InCentive Capital's unsolicited bid for the company.